
Sign up to save your podcasts
Or


Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Scientific American4
8282 ratings
Ben Wiegand, global head of the World without Disease Accelerator at Janssen, the Pharmaceutical Companies of Johnson & Johnson, talks about efforts to prevent a disease or to identify it in its earliest stages for more effective treatments.
Learn more about your ad choices. Visit megaphone.fm/adchoices

90,971 Listeners

31,987 Listeners

30,716 Listeners

11,034 Listeners

3,858 Listeners

215 Listeners

52 Listeners

1,382 Listeners

76 Listeners

59 Listeners

600 Listeners

822 Listeners

28,271 Listeners

43 Listeners

3,639 Listeners

29,170 Listeners